Diagnostic Microbiology and Emerging Infectious Diseases

Sep 09-10, 2019


Dubai, United Arab Emirates (UAE)

Conference on Diagnostic Microbiology and Emerging Infectious Diseases in 2019 in Dubai, UAE

LexisConferences conferences invite all the participants from all over the world to attend "Diagnostic Microbiology and Emerging Infectious Diseases Summit" to be held at Dubai, UAE during Septembe 09-10, 2019 on the Theme: “Expanding & Exploring the Possibilities of Diagnostic Microbiology in Infectious Diseases”.

Diagnostic Microbiology Conference assembles the scientific sessions with keynote speakers, plenary lectures, oral and poster communications, and roundtable discussions, panel discussion, debates and workshop along with an exhibition and networking opportunities for two info-packed days that will help them raise and excel in their role. This event provides a pivotal platform to explore outstanding strategies in Diagnostic Microbiology and Infectious Diseases.

Importance and Scope:

Diagnostic Microbiology and Emerging Infectious Disease keeps you informed of the latest development in medical and clinical and microbiology, diagnosis and treatment of infectious diseases.

The Conference will Provide an exceptional scientific program with exciting scientific session that will cover topics such as diagnostic microbiology, viral, bacterial and fungal infections antimicrobial resistance, emerging microbes, molecular biology, epidemiology and public health, blood stream infection, immunology, treatment and therapeutics, healthcare infection, clinical and medical diagnosis and sexually transmitted diseases through interactive presentation, panel discussion ,debates and workshop.

This conference invites all the delegates from universities, research field, hospitals, healthcare, public authorities to discuss and explore opportunities related to diagnostic microbiology and infectious diseases, and it’s significant. Academician, business and entrepreneur, researchers (doctorate and post-doctorate), microbiologist, biotechnologist, lab technicians, physicians, students are warmly invited to join and register our conference.

Target Audience:

Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Department
Directors of Associations and Societies
Researchers, Scientists, Faculties, Students
Clinical Microbiology and Pathology Associations and Societies
Medical Colleges
Pharmaceutical Companies and Industries
Medical Devices Manufacturing Companies
Drug Manufacturing Companies and Industries
Laboratory Technicians and Diagnostic Companies
Healthcare Industries
Business Entrepreneurs and Industrialists


Market Analysis:
Global Market Research Report:

The Global  Diagnostic microbiology  and Emerging Infectious Disease Market growth can be attributed to factors such as the technological advancements; rising incidence of infectious diseases and growing outbreak of epidemics; growing healthcare expenditure across the world; and increasing funding, research grants, and public-private investments in the field of life science research, prevalence of pathogenic diseases, growth in discovery of mutating and adapting bacterium, and the growing need for speedy microbiological testing methods.

The Global Diagnostic Microbiology Market is projected to reach USD 6.77 billion by 2024 From USD 4.99 billion in 2019, at a CAGR of 12.5%, during 2019 to 2024.

The microbiology laboratory has a whole array of diagnostics instruments used for serology, virus culture, and blood culture. This method is used for the detection of influenza viruses as well as a number of other diseases.

There has been an increase in the number of infectious diseases across the globe. The factors such as the rise in incidence of HIV and tuberculosis as well as sexually transmitted diseases in developing countries along with the rise in respiratory diseases like influenza in developed countries like Europe, America and Middle East will drive the microbiology market.

Similarly, factors like the consolidation of diagnostic laboratory chains and the increase in public awareness are driving the growth of the market. The emerging countries are expected to outperform the U.S. and European and Middle East countries. This is mainly due to the increase in the major hospital chains opening new centres in major cities as well as an increase in the government expenditure.

The pharmaceutical sector is one of the most innovative industries in Dubai. It is composed of Companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments. These include brand-name pharmaceutical companies, generic drug firms, biopharmaceutical small and medium sized enterprises (biopharmaceutical SMEs), and contract service providers (CSP).

Pharmaceutical Companies:

Gilead Sciences Middle East Office
Bayer Middle East FZE,
Novo Nordisk Pharma Gulf Fz Llc
NewBridge Pharmaceuticals Scientific Office
MPC Healthcare
EDA Pharmaceuticals
Eli Lilly & Company
Layal Pharmacy 


Scope of the Report:

- Market study assessments for the regional and country level segments.

-Market study analysis of the top industry players.

-To analyse the market based on various factors-price analysis, supply chain analysis, porters five force analysis etc.

-The global Diagnostic Microbiology market has been evaluated as rapidly growing market and expected that the market will reach high growth figures.

-To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

-There has been huge demand for Diagnostic Microbiology in the diagnostic ,biotechnology and pharmaceutical companies as well as reference laboratories.


Details of Diagnostic Microbiology and Emerging Infectious Diseases in 2019 in Dubai, UAE :

Conference Name Place Date
Diagnostic Microbiology Conference 2019 Dubai, UAE Sep 09-10, 2019
Sadaf Sabzevari
Vector-born Disease Research Centre,
North Khorasan University of Medical Science


Sadaf Sabzevari She has Ph.D. degree in Parasitology and DVM degree in Veterinary Medicine from Ferdowsi University of Mashhad, Iran. She is interested in the research subjects related to the infectious disease. As a top graduate student majoring in vete

Researches :

  • Microbiology, Parasitology and Infectious Diseases
Kayur Mehta
Pediatric Infectious Diseases Clinician - Researcher
Montreal Children's Hospital (McGill University)

Ghulam Dhabaan
Research Development
Dept of Microbiology
Mount Sinai Hospital

Researches :

  • 1. Antimicrobial resistance-Antibiotic Resistance 2- Infectious Disease-Mycology 2. Microbial Genetics & Molecular Biology 3. Infection control & Preventions
Arik Elfassy
Principal Scientist

Hafiz Ahmad
RAK Medical and Health Sciences University


Dr Hafiz Ahmad has extensive teaching and research experience in Medical and Molecular Microbiology. His past research focus has been on HIV/TB drug resistance and co-infections especially intestinal parasites. He has served as an Assistant professor of M

Researches :

  • His research team conducts research broadly in Diagnostic Microbiology and infectious disease encompassing: Microbiome, Diabetes, Exosomal microRNA, HIV & Tuberculosis, Intestinal Parasitic infections, HIV Genotyping and HIV Drug resistance, HPV and oral cancer, HBV/HCV molecular epidemiology, Diagnostic Microbiology & Molecular Diagnostics of Sexually Transmitted Diseases, Antibiotic activity and screening of natural plant products, Microbial diversity etc. At RAKMHSU, he leads various undergraduate student research projects apart from his core research and setting up of the central research lab. Dr Hafiz is the recipient of Hamdan award in 2016 for his outstanding work on liver disease at the 9th International conference of medical sciences by Sheikh Hamdan awards, Dubai for his research work entitled “Evaluation of Dried Blood Spot (DBS) as a method of sample collection for Hepatitis C Virus (HCV) RNA quantification”. Dr Hafiz also serve as reviewer and editorial board member of several medical scienti
Nnamdi Azikiwe University


Dr. Ozor, Nnamdi Sergius is currently a Specialist Registrar in Anatomical Pathology department of Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria. He has Bachelor’s degrees of Medicine and Surgery (MB, BS) from Nnamdi Azikiwe University Colle

Nabil Saad Harmal
Asia Metorpolitan University


Dr. Nabil has completed his PhD on 2011 from University Putra Malaysia and postdoctoral research followship for two years at University Putra Malaysia, Faculty of Medicine and Health Sciences. He is a seniour Lecturer at Asia Metorpolitan University, Fac

Researches :

  • Molecular Diagnosis, Epidemiological studies, Genotyping, Vaccine development, fundamental researches on microbial Immuno-pathogenicity, Drug resistance and Drug Discovery.
Hosam Fouad
Al Borg Medical Laboratories


Hosam Fouad is an accomplished laboratory executive with over 14 years' experience in the laboratory industry. Hosam is currently the Country Manager of Al Borg Medical Laboratories in the United Arab Emirates, the largest privately owned group of labor

Program Overview

Our Collaborations, Sponsors, Media Partners